{"slideshow_credits": null, "snippet": "Many Wall Street analysts and heart specialists are lukewarm about the drug, which has shown mixed results in clinical trials.", "abstract": "Food and Drug Administration approves Corlanor, drug used to treat chronic heart failure that has shown mixed results in clinical trials.", "section_name": "Business Day", "print_page": "19", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/04/16/business/fda-approves-amgen-drug-to-treat-heart-failure.html", "lead_paragraph": "Many Wall Street analysts and heart specialists are lukewarm about the drug, which has shown mixed results in clinical trials.", "headline": {"main": "F.D.A. Approves Amgen Drug to Treat Heart Failure", "print_headline": "F.D.A. Approves Drug to Treat Heart"}, "_id": "552ee37438f0d824112d66f5", "word_count": "633", "multimedia": [], "pub_date": "2015-04-16T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Heart", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Amgen Inc", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}